Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Procter & Gamble Hygiene and Health Care (BOM:500459) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Procter & Gamble Hygiene and Health Care Cash Conversion Cycle Related Terms
Procter & Gamble Hygiene and Health Care Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care Cash Conversion Cycle Chart
Procter & Gamble Hygiene and Health Care Annual Data
BOM:500459 vs PG, CL, KVUE: Cash Conversion Cycle Comparison
For the Household & Personal Products subindustry, Procter & Gamble Hygiene and Health Care's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Hygiene and Health Care Cash Conversion Cycle vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Hygiene and Health Care's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Hygiene and Health Care's Cash Conversion Cycle falls into.
Procter & Gamble Hygiene and Health Care Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Conversion Cycle of -136.65 mean?
Procter & Gamble Hygiene and Health Care (BOM:500459) has a Cash Conversion Cycle of -136.65 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Procter & Gamble Hygiene and Health Care and its competitors.
Is Procter & Gamble Hygiene and Health Care's Cash Conversion Cycle too high?
Procter & Gamble Hygiene and Health Care's current Cash Conversion Cycle is -136.65. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's Cash Conversion Cycle compare to PG and CL?
Procter & Gamble Hygiene and Health Care's Cash Conversion Cycle of -136.65 can be compared against companies in the Consumer Packaged Goods industry. The industry median Cash Conversion Cycle is 75.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Consumer Packaged Goods company?
The median Cash Conversion Cycle among Consumer Packaged Goods companies is 75.77, based on 1,952 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. For the Consumer Packaged Goods industry, the median Cash Conversion Cycle is 75.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Hygiene and Health Care's current Cash Conversion Cycle is -136.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹16,038.62, compared to a current price of ₹8,714.90 — trading 45.7% below its estimated fair value. The current Cash Conversion Cycle is -136.65. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current Cash Conversion Cycle is -136.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued.
The current stock price of ₹8,714.90 is trading 45.7% below its estimated GF Value™ of ₹16,038.62.
GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.
Key valuation signals for BOM:500459:
Cash Conversion Cycle: -136.65
GF Value™: ₹16,038.62 vs. price of ₹8,714.90 (45.7% below fair value)
No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Procter & Gamble Hygiene and Health Care Business Description
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
76GF Score
Get the complete analysis for BOM:500459
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500459 has been successfully added to your 
